Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13

European Journal of Cancer

Volumn 49, Issue 11, 2013, Pages 2531-2541

  Bachet, Jean Baptiste ^a,b,c   Landi, Bruno ^d   Laurent Puig, Pierre ^d,e   Italiano, Antoine ^f   Le Cesne, Axel ^g   Lévy, Philippe ^h   Safar, Violaine ⁱ   Duffaud, Florence ^j   Blay, Jean Yves ^k   Emile, Jean François ^a,l  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Oncology Department   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h BEAUJON HOSPITAL   (France)

ⁱ HENRI MONDOR HOSPITAL   (France)

^j TIMONE HOSPITAL   (France)

^k CENTRE LÉON BÉRARD   (France)

^l HÔPITAL AMBROISE PARÉ   (France)

more..

Author keywords

Gastrointestinal stromal; Germline mutation; Imatinib; KIT; p.K642E; Prognosis; tumour

Indexed keywords

IMATINIB;

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DYSPHAGIA; EXON; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; HUMAN TISSUE; ONCOGENE C KIT; PEDIGREE; PRIORITY JOURNAL; SPINDLE CELL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BENZAMIDES; EXONS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PEDIGREE; PIPERAZINES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; YOUNG ADULT;

EID: 84879290840     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.04.005     Document Type: Article

References (41)

1. P.A. Cassier, F. Ducimetière, and A. Lurkin A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region Br J Cancer 103 2010 165 170
2. J.F. Emile, N. Théou, and S. Tabone Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors Clin Gastroenterol Hepatol 2 2004 597 605
3. L.G. Kindblom, H.E. Remotti, F. Aldenborg, and J.M. Meis-Kindblom Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal Am J Pathol 152 1998 1259 1269
4. S. Hirota, K. Isozaki, and Y. Moriyama Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 1998 577 580
5. M.C. Heinrich, C.L. Corless, and A. Duensing PDGFRA activating mutations in gastrointestinal stromal tumors Science 299 2003 708 710
6. J.B. Bachet, and J.F. Emile Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors Appl Clin Genet 3 2010 85 101
7. C.D. Blanke, C. Rankin, and G.D. Demetri Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 J Clin Oncol 26 2008 626 632
8. H. Joensuu, M. Eriksson, and K. Sundby Hall One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor JAMA 307 2012 1265 1272
9. M. Debiec-Rychter, R. Sciot, and A. Le Cesne KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours Eur J Cancer 42 2006 1093 1103
10. E.P. Kleinbaum, A.J.F. Lazar, and E. Tamborini Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor Int J Cancer 122 2008 711 718
11. F.P. Li, J.A. Fletcher, and M.C. Heinrich Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred J Clin Oncol 23 2005 2735 2743
12. M.E. Zöller, B. Rembeck, A. Oden, M. Samuelsson, and L. Angervall Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population Cancer 79 1997 2125 2131
13. J.A. Carney, and C.A. Stratakis Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad Am J Med Genet 108 2002 132 139
14. M. Nakai, Y. Hashikura, and M. Ohkouchi Characterization of novel germline c-kit gene mutation, KIT-Tyr553Cys, observed in a family with multiple gastrointestinal stromal tumors Lab Invest 92 2012 451 457
15. M. Miettinen, and J. Lasota Gastrointestinal stromal tumors: pathology and prognosis at different sites Semin Diagn Pathol 23 2006 70 83
16. C.D. Fletcher, J.J. Berman, and C. Corless Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol 33 2002 459 465
17. J.F. Emile, A. Lemoine, and N. Bienfait Length analysis of polymerase chain reaction products: a sensitive and reliable technique for the detection of mutations in KIT exon 11 in gastrointestinal stromal tumors Diagn Mol Pathol 11 2002 107 112
18. K. Isozaki, B. Terris, and J. Belghiti Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors Am J Pathol 157 2000 1581 1585
19. T. Nishida, S. Hirota, and M. Taniguchi Familial gastrointestinal stromal tumours with germline mutation of the KIT gene Nat Genet 19 1998 323 324
20. B. Pasini, L. Matyakhina, and T. Bei Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect J Clin Endocrinol Metab 92 2007 3728 3732
21. A. Chompret, C. Kannengiesser, and M. Barrois PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor Gastroenterology 126 2004 318 321
22. J. Lasota, C.L. Corless, and M.C. Heinrich Clinicopathologic profile of gastrointestinal stromal tumors (GISYs) with primary KIT exon 13 or exon 17 mutations: a multicentre study of 54 cases Mod Pathol 21 2008 476 484
23. M. Miettinen, J.F. Fetsch, L.H. Sobin, and J. Lasota Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases Am J Surg Pathol 30 2006 90 96
24. A. Agaimy, B. Märkl, and H. Arnholdt Sporadic segmental interstitial cell of Cajal hyperplasia (microscopic GIST) with unusual diffuse longitudinal growth replacing the muscularis propria: differential diagnosis to hereditary GIST syndromes Int J Clin Exp Pathol 3 2010 549 556
25. Y. Chen, S. Hirota, and K. Isozaki Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours Gut 51 2002 793 796
26. T. Campbell, L. Felsten, and J. Moore Disappearance of lentigines in a patient receiving imatinib treatment for familial gastrointestinal stromal tumor syndrome Arch Dermatol 145 2009 1313 1316
27. C. O'Riain, C.L. Corless, and M.C. Heinrich Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features Am J Surg Pathol 29 2005 1680 1683
28. M.E. Robson, E. Glogowski, and G. Sommer Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia Clin Cancer Res 10 2004 1250 1254
29. S. Hirota, T. Nishida, and K. Isozaki Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene Gastroenterology 122 2002 1493 1499
30. H.T. Lee, G.W. Hennig, and N.W. Fleming The mechanism and spread of pacemaker activity through myenteric interstitial cells of Cajal in human small intestine Gastroenterology 132 2007 1852 1865
31. Y.O. Alahdab, F. Eren, and A. Giral Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population Neurogastroenterol Motil 24 2012 27 30
32. M.C. Heinrich, C.L. Corless, and G.D. Demetri Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor J Clin Oncol 21 2003 4342 4349
33. M. Debiec-Rychter, H. Dumez, and I. Judson Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 40 2004 689 695
34. M.C. Heinrich, K. Owzar, and C.L. Corless Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group J Clin Oncol 26 2008 5360 5367
35. M. Rössle, A. Hirschmann, and J. Diebold Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - a population-based study Eur J Cancer 47 2011 1305 1311
36. H.J. Kang, M.H. Ryu, and K.M. Kim Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): the Korean GIST Study Group (KGSG) study Acta Oncol 51 2012 528 536
37. J. Gao, Y. Dang, N. Sun, J. Li, and L. Shen C-KIT mutations were closely associated with the response to imatinib in Chinese advanced gastrointestinal stromal tumor patients Med Oncol 29 2012 3039 3045
38. J. Graham, M. Debiec-Rychter, and C.L. Corless Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation Arch Pathol Lab Med 131 2007 1393 1396
39. M.C. Heinrich, C.L. Corless, and C.D. Blanke Molecular correlates of imatinib resistance in gastrointestinal stromal tumors J Clin Oncol 24 2006 4764 4774
40. B. Landi, O. Bouché, R. Guimbaud, and J.A. Chayvialle Gastrointestinal stroma tumors (GIST) <5 cm in size: review of the literature and expert propositions for clinical management Gastroenterol Clin Biol 34 2010 120 133
41. J.Y. Blay, S. Bonvalot, and P. Casali Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST consensus conference of 20-21 March 2004, under the auspices of ESMO Ann Oncol 16 2005 566 578